# Evaluation of Efficacy of Botulinum Toxin A Plus Oral Tadalafil 5 mg in Diabetic Men With Erectile Dysfunction

> **NCT06583590** · PHASE2,PHASE3 · RECRUITING · sponsor: **Aswan University Hospital** · enrollment: 32 (estimated)

## Conditions studied

- Erectile Dysfunction With Diabetes Mellitus

## Interventions

- **DRUG:** Botulinum toxin A
- **DRUG:** Tadalafil 5mg

## Key facts

- **NCT ID:** NCT06583590
- **Lead sponsor:** Aswan University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-01
- **Primary completion:** 2025-08-31
- **Final completion:** 2025-12-01
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2024-12-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06583590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06583590, "Evaluation of Efficacy of Botulinum Toxin A Plus Oral Tadalafil 5 mg in Diabetic Men With Erectile Dysfunction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06583590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*